The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLSDays features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Dr. Ingrid Teigland Akay

Managing Partner, Hadean Ventures

10 Sep 09:15 Plenary Room Super Session 4

Dr. Sonia Benhamida

Senior Vice President Healthcare, DNB

10 Sep 09:15 Plenary Room Super Session 4

Dr. Magnus Björsne

CEO, Astrazeneca BioVentureHub

10 Sep 13:45 Plenary Room Super Session 6

Dr. Nikolai Brun

Chair HMA-EMA Taskforce on Big Data

9 Sep 11:15 Plenary Room Super Session 1

Ms. Karin Conde-Knape

CVP Global Diabetes, Cardio-Renal and Global Drug Discovery, Novo Nordisk

10 Sep 11:15 Plenary Room Super Session 5

Dr. Eric De La Fortelle

Venture Partner Seventure Partners

9 Sep 13:45 Plenary Room Super Session 2

Mr. Olivier Duchamp

Managing Director, NLSDays - NLS Invest

9 Sep 09:30 Plenary Room Opening Plenary

Dr. Per Falk

President and Chief Science Officer, Ferring Pharmaceuticals

9 Sep 13:45 Plenary Room Super Session 2

Mr. Erik Gatenholm

CEO and Co-Founder, Cellink

9 Sep 09:30 Plenary Room Opening Plenary

Ms. Carolina Haefliger

VP, Head Centre for Genomics Research, AstraZeneca

10 Sep 11:15 Plenary Room Super Session 5

Prof. Rob Knight

Founding Director of the Center for Microbiome Innovation and Professor at UC San Diego

9 Sep 13:45 Plenary Room Super Session 2

Ms. Sarah Lidé

Senior Strategy & Project Manager, Medicon Valley Alliance

9 Sep 13:45 Plenary Room Super Session 2

Mr. Emmanuel Ligner

CEO & President at Cityva (former GE Healthcare Life Sciences)

9 Sep 09:30 Plenary Room Opening Plenary

Dr. Lars Lindsköld

Portfolio manager, Sweper / Swelife

9 Sep 11:15 Plenary Room Super Session 1

Ms. Rajji Mehdwan

General Manager, Roche Norway

9 Sep 11:15 Plenary Room Super Session 1

Dr. Henrik Bjørn Nielsen

Chief Scientific Officer, Clinical Microbiomics

9 Sep 13:45 Plenary Room Super Session 2

Dr. Sam Oddsson

Chief Medical Officer & Co-Founder, SidekickHealth

10 Sep 13:45 Plenary Room Super Session 6

Mr. Martin Olovsson

CEO and Co-Founder, Ondosis

10 Sep 13:45 Plenary Room Super Session 6

Dr. Jessica Shull

European Lead, Digital Therapeutics Alliance

10 Sep 13:45 Plenary Room Super Session 6

Dr. Patrick Sobocki

Investment Manager, Industrifonden

10 Sep 11:15 Plenary Room Super Session 5

Dr. Per Sontum

CEO, Phoenix Solutions

9 Sep 09:30 Plenary Room Opening Plenary

Ms. Helena Strigård

Director General, SwedenBIO

9 Sep 09:30 Plenary Room Opening Plenary

Dr. Lennart Thurfjell

CEO, Combinostics

9 Sep 15:30 Plenary Room Super Session 3

Dr. Christina Trojel-Hansen

CEO and Co-Founder, Oscine Therapeutics

10 Sep 09:15 Plenary Room Super Session 4

Mr. Claes Watndal

CEO, Mentis Cura

9 Sep 15:30 Plenary Room Super Session 3